Aliya Jaber

FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance

Henry W. Long, Kristen L Jones, X. Liu, 2021, Nature Cell Biology.

COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy

J. Kalina, M. Tremblay, Jason P. Mendoza, 2023, Neurology and Therapy.